They also assessed carvacrol behavioral effects in that PD model using cylinder test, and evaluated caspase-3 levels by immunoblots and transient receptor potential melastatin (TRPM7), as major carvacrol targets. The gene discussed is CASP3; the disease is Parkinson disease.